| Primary |
| Hairy Cell Leukaemia |
11.5% |
| B-cell Lymphoma |
11.3% |
| Prophylaxis |
10.0% |
| Pyrexia |
6.8% |
| Drug Use For Unknown Indication |
6.3% |
| Infection Prophylaxis |
6.0% |
| Antifungal Prophylaxis |
5.8% |
| Mantle Cell Lymphoma |
5.0% |
| Product Used For Unknown Indication |
4.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
4.2% |
| Tonsillar Inflammation |
3.9% |
| Constipation |
3.7% |
| Extranodal Marginal Zone B-cell Lymphoma (Malt Type) |
3.6% |
| Infection |
2.7% |
| Non-hodgkin's Lymphoma |
2.6% |
| Antibiotic Prophylaxis |
2.4% |
| Chronic Lymphocytic Leukaemia |
2.4% |
| Hypertension |
2.4% |
| Pneumocystis Jiroveci Pneumonia |
2.4% |
| Analgesic Therapy |
2.3% |
|
| White Blood Cell Count Decreased |
31.4% |
| Thrombocytopenia |
13.3% |
| Pancytopenia |
5.7% |
| Pyrexia |
4.8% |
| Platelet Count Decreased |
3.8% |
| Pneumocystis Jiroveci Pneumonia |
3.8% |
| Respiratory Failure |
3.8% |
| Sepsis |
3.8% |
| White Blood Cell Disorder |
3.8% |
| Monocyte Count Decreased |
2.9% |
| Pharyngolaryngeal Pain |
2.9% |
| Rash |
2.9% |
| Stomatitis |
2.9% |
| Weight Increased |
2.9% |
| Blood Creatinine Increased |
1.9% |
| Cardiac Disorder |
1.9% |
| Glioblastoma |
1.9% |
| Hepatotoxicity |
1.9% |
| Liver Function Test Abnormal |
1.9% |
| Nerve Injury |
1.9% |
|
| Secondary |
| Mantle Cell Lymphoma |
11.4% |
| B-cell Lymphoma |
11.0% |
| Prophylaxis |
9.9% |
| Antifungal Prophylaxis |
9.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
7.2% |
| Hairy Cell Leukaemia |
6.8% |
| Atrial Fibrillation |
5.6% |
| Pyrexia |
5.6% |
| Infection Prophylaxis |
5.2% |
| Constipation |
4.6% |
| Hyperuricaemia |
3.2% |
| Prophylaxis Of Nausea And Vomiting |
3.1% |
| Abdominal Pain |
2.5% |
| Constipation Prophylaxis |
2.5% |
| Nasopharyngitis |
2.5% |
| Premedication |
2.5% |
| Myeloproliferative Disorder |
2.1% |
| Drug Use For Unknown Indication |
2.0% |
| Cardiac Failure |
1.8% |
| Anaemia |
1.3% |
|
| White Blood Cell Count Decreased |
43.9% |
| Thrombocytopenia |
11.2% |
| Pneumonitis Cryptococcal |
7.5% |
| Myeloproliferative Disorder |
4.7% |
| Sepsis |
4.7% |
| White Blood Cell Disorder |
4.7% |
| Neutrophil Count Decreased |
2.8% |
| Stomatitis |
2.8% |
| Weight Increased |
2.8% |
| Leukaemia |
1.9% |
| Pancytopenia |
1.9% |
| Tendon Rupture |
1.9% |
| Troponin Increased |
1.9% |
| White Blood Cell Count Increased |
1.9% |
| Bone Marrow Failure |
0.9% |
| Cytomegalovirus Test Positive |
0.9% |
| Inflammation |
0.9% |
| Pain In Jaw |
0.9% |
| Protein Total Decreased |
0.9% |
| Tonsillitis |
0.9% |
|
| Concomitant |
| Non-hodgkin's Lymphoma |
15.0% |
| Prophylaxis |
15.0% |
| Asthma |
10.0% |
| Blood Pressure |
10.0% |
| Chemotherapy |
10.0% |
| Cystitis |
10.0% |
| Angina Pectoris |
5.0% |
| Drug Use For Unknown Indication |
5.0% |
| Fungal Skin Infection |
5.0% |
| Gastrointestinal Fungal Infection |
5.0% |
| Rash Pruritic |
5.0% |
| Restless Legs Syndrome |
5.0% |
|
| Headache |
9.1% |
| Leukaemic Infiltration Gingiva |
9.1% |
| Lung Neoplasm |
9.1% |
| Lung Neoplasm Malignant |
9.1% |
| Neutropenia |
9.1% |
| Sensory Disturbance |
9.1% |
| Thrombocytopenia |
9.1% |
| Tongue Blistering |
9.1% |
| Tremor |
9.1% |
| Urticaria |
9.1% |
| Weight Decreased |
9.1% |
|
